Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 20, 2026

  1. Stopped: Selinexor (KPT-330) · Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Trial terminated Karyopharm Therapeutics IncPhase 2 NCT02227251
  2. Stopped: Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults Withdrawn before enrolling Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 1 NCT07455084
  3. Stopped: NMS-03597812 · Relapsed/Refractory Acute Myeloid Leukemia Trial terminated Nerviano Medical SciencesPhase 1 NCT06549790
  4. Stopped: EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment Trial terminated BrainQ Technologies Ltd.Not applicable NCT06386874
  5. Stopped: Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose · Iron Deficiency in Pregnancy Trial terminated Saskatchewan Health Authority - Regina AreaPhase 3 NCT05251493
  6. Stopped: NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy Trial status changed: Not Yet Recruiting → Suspended M.D. Anderson Cancer CenterPhase 2 NCT07227909
  7. Stopped: Oxytocin/Foley vs. Oxytocin for Induction · PPROM Trial terminated Eastern Virginia Medical SchoolPhase 4 NCT07119398
  8. Stopped: Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients Trial status changed: Recruiting → Withdrawn Instituto de Investigación Sanitaria de la Fundación Jiménez DíazPhase 1/2 NCT06968000
  9. Stopped: Enhanced PSMA CAR- T in Refractory CRPC Trial status changed: Active, Not Recruiting → Suspended Shanghai Changzheng HospitalEarly Phase 1 NCT06228404
  10. Stopped: Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP Trial status changed: Recruiting → Withdrawn The Foundation for Orthopaedics and Regenerative MedicinePhase 1 NCT05018871
  11. Stopped: Universal PSMA CAR- T in Refractory CRPC Trial status changed: Active, Not Recruiting → Suspended Shanghai Changzheng HospitalPhase 1 NCT06895811
  12. Stopped: Vagus Nerve Stimulation to Enhance Memory in Aging Withdrawn before enrolling Stanford UniversityNot applicable NCT07214194
  13. Stopped: Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery Trial terminated Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot specified NCT06425874
  14. Stopped: Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis Withdrawn before enrolling Stanford UniversityNot applicable NCT07559448
  15. Stopped: EFT for Transdiagnostic Eating Disorders/Difficulties Within Student Counselling Services Trial status changed: Enrolling by Invitation → Terminated Canterbury Christ Church UniversityNot applicable NCT06779838
  16. Stopped: Physiological Effects of ANGPTL3 Variants in Humans Trial status changed: Recruiting → Withdrawn University of PennsylvaniaNot applicable NCT04234724
  17. Stopped: Removal of Intrauterine Retained Products of Conception (RPOC) After Miscarriage Guided by Hysteroscopy Trial. A Randomized Controlled Trial Trial terminated University Hospital, GhentNot applicable NCT04804332
  18. Stopped: Cardiopulmonary Exercise Testing in Cardiosurgery Patients Trial terminated St. Anne's University Hospital Brno, Czech RepublicNot specified NCT06702059
  19. Stopped: 4T Sustainability Program Trial status changed: Enrolling by Invitation → Withdrawn Stanford UniversityNot specified NCT06314048
  20. Stopped: Vertical Soft Tissue Augmentation With CTG vs ADM Trial terminated Harvard Medical School (HMS and HSDM)Not applicable NCT05729607
  21. Stopped: Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group Trial terminated University of Rhode IslandNot applicable NCT05363878
  22. Stopped: ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes Withdrawn before enrolling Baylor Research InstituteNot applicable NCT07460583
  23. Notable: Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder Enrollment reduced: 180 → 120 participants New York State Psychiatric InstitutePhase 2/3 NCT05011266
  24. Notable: Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) Enrollment reduced: 1944 → 1117 participants Instituto de Investigación Marqués de ValdecillaPhase 4 NCT07611747
  25. Notable: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer Enrollment reduced: 1760 → 1150 participants Isabelle HenskensNot applicable NCT07146295